Technical Support
(877) SEPAX-US, press 3      
TechSupport@sepax-tech.com

Representative Literature References

Click a row to open its literature reference.
Product PN Separation Mode
Broad Sample Type Specific Sample
Previous   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   Next   View All
Year Product PN Sep. Mode Broad Sample Category Specific Sample Title
2013Polar-ImidazoleN/AOTHEROthersN/ADifferential Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on Motor Behavior and Dopamine Levels at Brain Regions in Three Different Mouse Strains
Korean J Physiol Pharmacol., 17(1), 89-97
2013Nanofilm SEC-500N/ASECProteinN/AStructure of a PLS-class Pentatricopeptide Repeat Protein Provides Insights into Mechanism of RNA Recognition
Journal of Biological Chemistry, 288, 31540-31548
2013Zenix SEC-300N/ASECFusion ProteinN/ACoupled affinity and sizing chromatography: A novel in-process analytical tool to measure titer and trend Fc-protein aggregation
Journal of Immunological Methods, Volume 393, Issues 1-2, Pages 81-85
2013Zenix SEC-300N/ASECPEG/PEGylated ProteinN/AOptimization of random PEGylation reactions by means of high throughput screening
Biotechnology and Bioengineering, Volume 111, Issue 1, pages 104-114
2013Zenix SEC-300N/ASECBispecific AntibodyN/AKnobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity
MAbs, 5(6), 872-81
2013SRT SEC-300N/ASECMembrane ProteinN/ASteroid-based facial amphiphiles for stabilization and crystallization of membrane proteins
PNAS, vol. 110 no. 13
2013SRT SEC-300215300-7830SECFusion ProteinALK1-Fc fusion proteinCharacterization of Fc-fusion protein aggregates derived from extracellular domain disulfide bond rearrangements
Journal of pharmaceutical sciences 102.2 (2013): 441-453.
2013SRT SEC-300N/ASECMembrane ProteinN/AThe rhodopsin-transducin complex houses two distinct rhodopsin molecules
Journal of Structural Biology, Volume 182, Issue 2, Pages 164-172
2013Zenix SEC-300N/ASECADCN/ATrastuzumab-Doxorubicin Conjugate Provides Enhanced Anti-Cancer Potency and Reduced Cardiotoxicity
Journal of Cancer Therapy, Vol.4 No.1
2012SRT SEC-500N/ASECBsMAbant-TNF-ang2 bsMabSimultaneous targeting of TNF and Ang2 with a novel bispecific antibody enhances
Previous   1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   Next   View All
© 2024 Sepax Technologies, Inc. All Rights Reserved.